Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers

Journal of Controlled Release

Volumn 95, Issue 3, 2004, Pages 515-520

  Korhonen, Ossi ^a   Kanerva, Harri ^a   Vidgren, Mika ^a   Urtti, Arto ^a   Ketolainen, Jarkko ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Controlled drug release; IVIVC; Matrix tablet; Pharmacokinetics; Starch acetate

Indexed keywords

ERROR ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHARMACOKINETICS; PLASMAS; STARCH;

DRUG RELEASES; PREDICTION ERRORS;

DRUG PRODUCTS;

DILTIAZEM; STARCH; STARCH ACETATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG FORMULATION; ERROR; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TABLET;

ADMINISTRATION, ORAL; ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DILTIAZEM; FEMALE; HUMANS; MALE; PARTICLE SIZE; STARCH; TABLETS; TECHNOLOGY, PHARMACEUTICAL;

EID: 1542404792     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2003.12.026     Document Type: Article

References (8)

1. Korhonen O., Raatikainen P., Harjunen P., Nakari J., Suihko E., Peltonen S., Vidgren M., Paronen P. Starch acetates - multifunctional direct compression excipients. Pharm. Res. 17:2000;1138-1143.
2. Korhonen O., Pohja S., Peltonen S., Suihko E., Vidgren M., Paronen P., Ketolainen J. Effects of physical properties for starch acetate powders on tableting. AAPS Pharm. Sci. Tech. 3:(4):2002;. Article 34 (http://www. aapspharmscitech.org).
3. S. Pohja, E Suihko, M. Vidgren, P. Paronen, J. Ketolainen, Starch acetate as a tablet matrix for sustained drug release, J. Control. Rel. (in press).
4. Raatikainen P., Korhonen O., Peltonen S., Paronen P. Acetylation enhances the tabletting properties of starch. Drug. Dev. Ind. Pharm. 28:2002;165-175.
5. FDA guidance for industry: extended release oral dosage forms: development, evaluation, and application of in vitro/in vivo correlations. September 1997.
6. Balan G., Timmins P., Greene D.S., Marathe P.H. In vitro-in vivo correlation (IVIVC) models for metformin after administration of modified-release (MR) oral dosage forms to healthy human volunteers. J. Pharm. Sci. 90:2001;1176-1185.
7. Hoglund P., Nilsson L.G. Pharmacokinetics of diltiazem and its metabolites after single and multiple dosing in healthy volunteers. Ther. Drug Monit. 11:1989;558-566.
8. Qiu Y., Samara E.E., Cao G. In vitro-in vivo correlations in the development of solid oral controlled release dosage forms. Wise D.L. Handbook of Pharmaceutical Controlled Release Technology. vol. 1:2000;527-549 Marcel Dekker, New York.